Last year of residency for oncologists : Overview and perspectives
Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved..
CONTEXT: The reform of the third cycle of medical studies in France has introduced of the "Junior Doctor" status during the concluding year of residency. We wish to evaluate its implementation for the first promotion of medical oncology residents during 2021-2022 in correlation with the published guidelines.
METHOD: AERIO conducted a cross-sectional study among French medical oncology residents. The survey was released via social networks and emails.
RESULTS: Twenty-eight of 47 residents responded. The typical week involved one to two half-days of consultation, one dedicated to clinical research, one multidisciplinary team meetings, with the rest of time being occupied by day care (mostly) and hospitalization. Teaching and quality management activities were infrequent (monthly or less). The Junior Doctors rated their overall satisfaction at 8/10. A large majority (92.5 %) felt equipped to handle most of the situations they encountered. Almost all residents (92.9 %) had negotiated with their placement supervisor prior to the selection procedure. In one third of the cases (35.7 %), the principle of mismatch between the number of residents and the number of training sites was not respected. Only 42.9 % received training in scientific writing and 82.2 % of the residents agreed on the relevance of the post-internship training modules developed in other specialties.
CONCLUSIONS: Junior doctors in medical oncology express overall satisfaction with this reform, which aligns with the recommendations. Nevertheless, certain concerns, such as selection procedure and inadequacy, along with areas requiring improvement, such as post-internship training and scientific writing, are clearly established.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:111 |
|---|---|
| Enthalten in: |
Bulletin du cancer - 111(2024), 2 vom: 15. Feb., Seite 142-152 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Premiers docteurs juniors d’oncologie médicale : état des lieux et perspectives |
|---|
| Beteiligte Personen: |
Laune, Quentin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Consolidation |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bulcan.2023.08.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36337857X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36337857X | ||
| 003 | DE-627 | ||
| 005 | 20240214232843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.bulcan.2023.08.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM36337857X | ||
| 035 | |a (NLM)37845094 | ||
| 035 | |a (PII)S0007-4551(23)00367-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Laune, Quentin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Last year of residency for oncologists |b Overview and perspectives |
| 246 | 3 | 3 | |a Premiers docteurs juniors d’oncologie médicale : état des lieux et perspectives |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a CONTEXT: The reform of the third cycle of medical studies in France has introduced of the "Junior Doctor" status during the concluding year of residency. We wish to evaluate its implementation for the first promotion of medical oncology residents during 2021-2022 in correlation with the published guidelines | ||
| 520 | |a METHOD: AERIO conducted a cross-sectional study among French medical oncology residents. The survey was released via social networks and emails | ||
| 520 | |a RESULTS: Twenty-eight of 47 residents responded. The typical week involved one to two half-days of consultation, one dedicated to clinical research, one multidisciplinary team meetings, with the rest of time being occupied by day care (mostly) and hospitalization. Teaching and quality management activities were infrequent (monthly or less). The Junior Doctors rated their overall satisfaction at 8/10. A large majority (92.5 %) felt equipped to handle most of the situations they encountered. Almost all residents (92.9 %) had negotiated with their placement supervisor prior to the selection procedure. In one third of the cases (35.7 %), the principle of mismatch between the number of residents and the number of training sites was not respected. Only 42.9 % received training in scientific writing and 82.2 % of the residents agreed on the relevance of the post-internship training modules developed in other specialties | ||
| 520 | |a CONCLUSIONS: Junior doctors in medical oncology express overall satisfaction with this reform, which aligns with the recommendations. Nevertheless, certain concerns, such as selection procedure and inadequacy, along with areas requiring improvement, such as post-internship training and scientific writing, are clearly established | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Consolidation | |
| 650 | 4 | |a Consolidation phase | |
| 650 | 4 | |a Docteur junior | |
| 650 | 4 | |a Formation | |
| 650 | 4 | |a Interne | |
| 650 | 4 | |a Junior doctor | |
| 650 | 4 | |a Oncologie | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Resident | |
| 650 | 4 | |a Teaching | |
| 700 | 1 | |a Varnier, Romain |e verfasserin |4 aut | |
| 700 | 1 | |a Rousseau, Adrien |e verfasserin |4 aut | |
| 700 | 1 | |a Larnaudie, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Ghannam, Youssef |e verfasserin |4 aut | |
| 700 | 1 | |a Huguet, Florence |e verfasserin |4 aut | |
| 700 | 1 | |a Delaye, Matthieu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 111(2024), 2 vom: 15. Feb., Seite 142-152 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
| 773 | 1 | 8 | |g volume:111 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:142-152 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bulcan.2023.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 111 |j 2024 |e 2 |b 15 |c 02 |h 142-152 | ||